Infection Control Market Overview

The global infection control market is witnessing sustained growth as healthcare systems worldwide intensify efforts to reduce healthcare-associated infections (HAIs), improve patient safety, and comply with stringent regulatory standards. According to recent market research, the market is projected to grow from USD 57.31 billion in 2025 to USD 77.67 billion by 2030, registering a CAGR of 6.3% during the forecast period.

The market is being driven by increasing surgical volumes, the growing burden of healthcare-associated infections, expanding pharmaceutical and medical device manufacturing, and the rising adoption of advanced sterilization, cleaning, and disinfection technologies. As infection prevention becomes a strategic priority across healthcare and life sciences, investments in innovative infection control solutions continue to accelerate.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084

Key Factors Driving Market Growth

Rising Incidence of Healthcare-Associated Infections (HAIs)

Healthcare-associated infections remain one of the biggest challenges facing hospitals and healthcare facilities worldwide. The growing need to prevent cross-contamination and improve patient outcomes is driving continuous investment in sterilization, disinfection, and infection prevention products.

Increasing Number of Surgical Procedures

The rising volume of surgical interventions globally has significantly increased demand for sterilized instruments, personal protective equipment (PPE), and effective environmental disinfection solutions. Every surgical procedure requires strict infection prevention protocols, supporting long-term market growth.

Expansion of Pharmaceutical and Medical Device Manufacturing

As pharmaceutical companies and medical device manufacturers expand production, demand for validated sterilization services and contamination control technologies continues to rise. Sterile manufacturing environments have become essential to ensure product quality, regulatory compliance, and patient safety.

Growing Adoption of Outsourced Sterilization Services

Many healthcare providers and life science companies are increasingly outsourcing sterilization services—including ethylene oxide (EtO), gamma irradiation, and electron beam (E-beam) sterilization—to specialized service providers. Outsourcing helps reduce operational costs, improve efficiency, and ensure compliance with evolving regulatory requirements.

Stronger Regulatory Compliance and Patient Safety Initiatives

Healthcare organizations are strengthening infection prevention strategies to comply with national and international accreditation standards. Continuous investments in advanced sterilization equipment, disinfection technologies, and automated infection control systems are becoming essential components of quality healthcare delivery.

Cleaning & Disinfection Products Expected to Witness the Fastest Growth

Among product categories, cleaning and disinfection products are expected to register the fastest growth during the forecast period.

These products play a vital role in preventing pathogen transmission across hospitals, laboratories, pharmaceutical facilities, and public healthcare environments.

Growing adoption is supported by:

• Routine environmental cleaning protocols
• Rising demand for surface disinfectants and wipes
• Increased focus on infection prevention
• Greater awareness of cross-contamination risks
• Ease of use and broad clinical applicability
• Compliance with infection prevention guidelines

As healthcare facilities continue strengthening hygiene protocols, cleaning and disinfection solutions are expected to remain among the most widely used infection control products worldwide.

Hospitals & Clinics Continue to Lead Market Demand

By end user, hospitals and clinics accounted for the largest share of the infection control market in 2024.

Their leadership is driven by several critical factors:

• High patient volumes
• Frequent surgical and invasive procedures
• Continuous use of reusable medical instruments
• Strict regulatory compliance requirements
• Ongoing investments in patient safety initiatives

Hospitals require comprehensive infection prevention strategies that include sterilization equipment, disinfectants, protective barriers, endoscope reprocessing systems, and personal protective equipment to minimize the risk of healthcare-associated infections.

North America Maintains Market Leadership

North America accounted for the largest share of the global infection control market in 2024 and is expected to retain its leadership throughout the forecast period.

Key growth drivers include:

• Advanced healthcare infrastructure
• High healthcare expenditure
• Strong regulatory oversight
• High adoption of automated sterilization technologies
• Growing prevalence of healthcare-associated infections
• Large number of surgical procedures
• Presence of leading infection control manufacturers

The United States continues to lead regional growth due to ongoing investments in hospital infection prevention programs, pharmaceutical manufacturing, and advanced sterilization technologies.

Meanwhile, the Asia-Pacific region is expected to experience robust growth as healthcare infrastructure expands, surgical procedures increase, and governments invest in stronger infection prevention initiatives.

Emerging Trends Shaping the Infection Control Market

Several technological and operational trends are transforming infection prevention worldwide:

• Expansion of low-temperature sterilization technologies
• Growing use of hydrogen peroxide vapor sterilization
• Increased adoption of E-beam and gamma sterilization services
• Automated room and equipment disinfection systems
• Smart monitoring of sterilization cycles
• AI-enabled infection surveillance platforms
• Increased demand for sustainable disinfectants
• Advanced endoscope reprocessing technologies
• Digital compliance tracking and workflow automation
• Expansion of infection prevention programs across outpatient settings

These innovations are helping healthcare providers improve operational efficiency while strengthening patient and staff safety.

Competitive Landscape

The infection control market is highly competitive, with manufacturers focusing on technological innovation, strategic partnerships, geographic expansion, and regulatory compliance.

Leading companies include:

• STERIS
• Reckitt Benckiser Group plc.
• Fortive
• Sotera Health
• Solventum
• Getinge AB
• Ecolab, Inc.
• Olympus Corporation
• Envista
• PAUL HARTMANN AG

These organizations continue investing in advanced sterilization equipment, infection prevention products, environmental hygiene solutions, and outsourced sterilization services to address the evolving needs of healthcare providers and life science companies.

Future Outlook

Infection prevention has become a fundamental pillar of modern healthcare delivery. As surgical volumes continue to rise, healthcare-associated infections remain a persistent challenge, and regulatory standards become increasingly stringent, demand for advanced infection control solutions is expected to remain strong.

Innovations in sterilization technologies, automated disinfection systems, digital infection surveillance, and outsourced sterilization services will continue transforming the industry over the next decade.

With the market projected to reach USD 77.67 billion by 2030, infection control will remain a strategic investment area for hospitals, pharmaceutical manufacturers, medical device companies, laboratories, and healthcare providers worldwide. Organizations that embrace innovation, strengthen compliance, and prioritize patient safety will be best positioned to capitalize on the growing opportunities within this dynamic global market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1084